392 related articles for article (PubMed ID: 9050197)
1. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
[TBL] [Abstract][Full Text] [Related]
2. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions.
Tiling R; Sommer H; Pechmann M; Moser R; Kress K; Pfluger T; Tatsch K; Hahn K
J Nucl Med; 1997 Jan; 38(1):58-62. PubMed ID: 8998151
[TBL] [Abstract][Full Text] [Related]
3. Complementary role of adjunctive breast magnetic resonance imaging and scintimammography in patients of all ages undergoing breast cancer surgery.
Howarth D; Slater S; Lau P; Booker J; Clark D; Sillar R
Australas Radiol; 2005 Aug; 49(4):289-97. PubMed ID: 16026435
[TBL] [Abstract][Full Text] [Related]
4. Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study.
Duarte GM; Cabello C; Torresan RZ; Alvarenga M; Telles GH; Bianchessi ST; Caserta N; Segala SR; de Lima Mda C; Etchebehere EC; Camargo EE; Tinois E
Ann Surg Oncol; 2007 Oct; 14(10):2903-10. PubMed ID: 17632758
[TBL] [Abstract][Full Text] [Related]
5. Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography.
Tiling R; Khalkhali I; Sommer H; Linke R; Moser R; Willemsen F; Pfluger T; Tatsch K; Hahn K
Nucl Med Commun; 1998 Jan; 19(1):55-62. PubMed ID: 9515547
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Imaging: Can Tc-99m Sestamibi Scintimammography Fit In?
Iraniha S; Khalkhali I; Cutrone JA; Diggles L; Klein SR
Medscape Womens Health; 1997 Apr; 2(4):2. PubMed ID: 9746689
[TBL] [Abstract][Full Text] [Related]
7. Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms.
Tiling R; Khalkhali I; Sommer H; Moser R; Meyer G; Willemsen F; Pfluger T; Tatsch K; Hahn K
Eur J Nucl Med; 1997 Oct; 24(10):1221-9. PubMed ID: 9323262
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
Helbich TH; Becherer A; Trattnig S; Leitha T; Kelkar P; Seifert M; Gnant M; Staudenherz A; Rudas M; Wolf G; Mostbeck GH
Radiology; 1997 Feb; 202(2):421-9. PubMed ID: 9015068
[TBL] [Abstract][Full Text] [Related]
9. Detection and prediction of breast cancer using double phase Tc-99m MIBI scintimammography in comparison with MRI.
Kim IJ; Kim YK; Kim SJ
Onkologie; 2009 Oct; 32(10):556-60. PubMed ID: 19816071
[TBL] [Abstract][Full Text] [Related]
10. [The MRT of the breast with 2D-spin-echo and gradient-echo sequences in diagnostically problematic cases].
Allgayer B; Lukas P; Loos W; Kersting-Sommerhoff B
Rofo; 1993 May; 158(5):423-7. PubMed ID: 8490150
[TBL] [Abstract][Full Text] [Related]
11. Tc 99m-Sestamibi scintimammography in the differentiation of benign and malignant breast microcalcifications.
Marini C; Cilotti A; Traino AC; Bellina CR; Grosso M; Armillotta N; Volterrani D; Bartolozzi C
Breast; 2001 Aug; 10(4):306-12. PubMed ID: 14965599
[TBL] [Abstract][Full Text] [Related]
12. [Dynamic imaging with magnetic resonance in the diagnosis of breast disease].
Ercolani P; Giovagnoni A; Giuseppetti G; Baldassarre S; De Nigris E; Amici F
Radiol Med; 1991 Oct; 82(4):422-6. PubMed ID: 1767046
[TBL] [Abstract][Full Text] [Related]
13. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid.
Kaiser WA
Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):539-55. PubMed ID: 7489307
[TBL] [Abstract][Full Text] [Related]
14. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
15. Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography.
Tiling R; Kessler M; Untch M; Sommer H; Linke R; Hahn K
Eur J Radiol; 2005 Feb; 53(2):206-12. PubMed ID: 15664284
[TBL] [Abstract][Full Text] [Related]
16. [Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast].
Fischer U; Vosshenrich R; Kopka L; Kahlen O; Grabbe E
Bildgebung; 1996 Jun; 63(2):94-100. PubMed ID: 8756151
[TBL] [Abstract][Full Text] [Related]
17. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
18. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging.
Palmedo H; Grünwald F; Bender H; Schomburg A; Mallmann P; Krebs D; Biersack HJ
Eur J Nucl Med; 1996 Aug; 23(8):940-6. PubMed ID: 8753683
[TBL] [Abstract][Full Text] [Related]
19. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
[TBL] [Abstract][Full Text] [Related]
20. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
